← Back to news

Markets

Why shoppers queue 40 minutes for their favourite cashier

Y

DraftKings (DKNG) Q4 2025 Earnings Call Transcript

Y

Here’s What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN)

Y

BofA Raises PT on Gilead Sciences (GILD) to $162 From $154 – Here’s Why

Y

Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 – Here’s Why

Y

Here’s What Analysts Are Saying About Bristol-Myers Squibb Company (BMY)

Y

Where is Regeneron Pharmaceuticals (REGN) Headed According to Analysts?

Y

Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds?

Y

Merck & Co. (MRK) Announces FDA Approval of KEYTRUDA® and KEYTRUDA QLEX™ Plus Paclitaxel, With or Without Bevacizumab, to Treat Adults With PD-L1+

Y

Where is AbbVie Inc. (ABBV) Headed According to the Street?

Y

Why is Johnson & Johnson (JNJ) One of the Best Medical Research Stocks to Buy According to Hedge Funds?

Y

Eli Lilly and Company (LLY) Gets Upgraded to Buy From Hold by Freedom Capital

Y

Claude maker Anthropic's annualized revenue up 1,300%

Y

Pizza Hut’s South Korean unit set for ownership change under court supervision

Y

KeyBanc Raises Monolithic Power Systems (MPWR) Price Target on Record Quarterly Revenue

Y

Royal Caribbean (RCL) Named Best-in-Class Cruise Operator by JPMorgan

Y

CIBC Boosts Agnico Eagle (AEM) Target on Strong Gold Price Forecast

Y

Vertex Pharma (VRTX) Renal Pipeline Seen as Major Growth Driver by Barclays

Y

Coinbase (COIN) Seen as Strong Crypto Franchise by Baird, Starts Coverage With Neutral Rating

Y

Robinhood (HOOD) Stock Selloff May Be Overblown, Said Truist

Y

Analysts Highlight Palantir’s (PLTR) Unique Software Financial Profile

Y

Deutsche Bank Bullish on AppLovin (APP) After Sharp Pullback Following Project Genie Announcement

Y

Eli Lilly (LLY) Retains Buy Rating on Strong 2026 Outlook

Y

Goldman Sachs Expects Beat and Raise Quarter for NVIDIA (NVDA)

Y

Roth Capital Upgrades Roblox (RBLX) to Buy

Y

TD Cowens Cuts Target on e.l.f. Beauty (ELF) to $100

Y

Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800

Y

Mizuho Trims Target Price on Affirm (AFRM) to $95

Y

William Blair Initiates Coverage on Dave (DAVE)

Y

Clear Street Trims Price Target on CleanSpark (CLSK) to $22, as Bitcoin Prices Fall

Y

Bernstein Trims Target Price on Oracle (ORCL) to $313

Y

JP Morgan Reduces Price Target on Spotify (SPOT) to $700

Y

Wedbush Cuts Target Price on Unity (U) to $30, Due to AI Concerns

Y

Roth Capital Cuts TP on Credo Technology (CRDO) to $200

Y

Wendy’s Sales Dented by Persistent U.S. Struggles

Y

Pinterest downgraded, Airbnb upgraded: Wall Street's top analyst calls

Y

Advance Auto Parts AAP Q4 2025 Earnings Transcript

Y

January CPI shows inflation slowing — but not housing costs

Y

Musk’s bankers are discussing a plan to wrangle xAI debt after SpaceX merger

Y

US Commerce Dept gives initial backing to Sibanye-Stillwater's call for tariffs on Russian palladium

Y

Rivian surges over 20% on delivery guidance, R2 launch in Q2; CEO says 'key inflection' reached

Y

Rivian Surges On Upgrades As Attention Turns To Its New Tesla Model Y Competitor

Y

TD Cowen Presented a Bullish Stance on Franklin Resources (BEN)

Y

Is AGNC Investment Stock a Millionaire Maker?

Y

3 Monster Stocks to Hold for the Next 3 Years

Y

Why Did Rigetti Computing Stock Plunge This Week?

Y

Apple CEO Tim Cook Says Company Doesn't Usually Look Back, But Will Celebrate 50th Anniversary: 'I Promise'

Y

Exclusive-US Fed to tap former Wall Street lawyer Guynn for top bank oversight role, say sources

Y

Gold and Silver Climb to Finish Week In Positive Territory

Y

FactSet (FDS) Target Lowered by Wells Fargo Amid AI Concerns in Info Services

Y